<DOC>
	<DOCNO>NCT02253472</DOCNO>
	<brief_summary>The purpose clinical study To verify long term effectiveness safety bilateral deep brain stimulation ( DBS ) produce Beijing PINS Medical Co. , Ltd. treatment option patient cognitive , behavioral , functional disability Obsessive-Compulsive Disorder .</brief_summary>
	<brief_title>The Safety Efficacy Long-term Treatment PINS Stimulator System Patients With Obsessive-Compulsive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<criteria>1 . Obsessive compulsive disorder ( accord DSM IVcriteria ) primary psychiatric diagnosis . 2 . Severity level OCD 25 YaleBrown Obsessive Compulsive Scale . 3 . Course illness present least five year chronic progressive form despite treatment trial ( treatment resistance ) . 4 . Treatment resistance : least two serotonin reuptake inhibitor ( SSRIÂ´s ) , one SSRI clomipramine 5.Sufficient dosage least 10 week , augmentation trial lithium , buspirone neuroleptic Lasting least 10 week , complete cognitivebehavioral psychotherapy , include `` exposure response Prevention '' minimum 20 session document lack efficiency . 6.The ability give write informed consent . 1 . Comorbid psychotic disorder accord DSMIV criterion 2 . Suicidal tendencies last 6 month 3 . History cerebral trauma 4 . Clinically relevant internal neurological disorder 5 . Substance misuse dependence last six month 6 . Ineligibility fulfill neurosurgical anesthesiological precondition implantation DBS 7 . Participate clinical trial 8 . The investigator and/or enrollment review committee , would preclude participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>